The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The error of determination of toxicity
Trevan, J. W. (1927) · Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character · doi:10.1098/rspb.1927.0030 · Cited by 390
Research works printed but not linked: 9
- W. Wiechowski, Verhandl. der Dtsch. Pharmakol. Ges., Würzburg 1927, S. 135 im Arch. f. exp. Pathol. u. Pharmakol. 1928, Bd. 128. · doi:10.1007/bf02130186
- B. Behrens,Ebenda, 1929, Bd. 140, S. 237.
- Saburo Miyasaki,Ebenda, 1929, Bd. 145, S. 217.
- O. Eichler,Ebenda, 1930, Bd. 154, S. 59.
- M. Kochmann,Ebenda, 1930, Bd. 152, S. 47.
- H. Langecker, Arch. f. exp. Pathol. u. Pharmakol. 1928, Bd. 136, S. 257. · doi:10.1007/bf01861624
- Trevan und Book, zitiert nach E. Knaffl-Lenz,Ebenda 1928, Bd. 135, S. 259. · doi:10.1007/bf01930516
- J. H. Burn, Physiol. review 1930, Bd. 10, S. 146. · doi:10.1152/physrev.1930.10.1.146
- S. Janssen und A. Loeser, Arch. f. exp. Pathol. u. Pharmakol. 1930, Bd. 151, S. 188. · doi:10.1007/bf01862463
Cited by
Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
Herfst, S., Schrauwen, E. J. A., Linster, M., Chutinimitkul, S., de Wit, E., Munster, V. J., Sorrell, E. M., Bestebroer, T. M., Burke, D. F., Smith, D. J., et al. (2012) · Science · doi:10.1126/science.1213362 · Cited by 1,665
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
Hui, K. P. Y., Ho, J. C. W., Cheung, M.-C., Ng, K.-C., Ching, R. H. H., Lai, K.-L., Kam, T. T., Gu, H., Sit, K.-Y., Hsin, M. K. Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04479-6 · Cited by 836
Determination of 50% endpoint titer using a simple formula
Ramakrishnan, M. A. (2016) · World Journal of Virology · doi:10.5501/wjv.v5.i2.85 · Cited by 752
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
Peacock, T. P., Goldhill, D. H., Zhou, J., Baillon, L., Frise, R., Swann, O. C., Kugathasan, R., Penn, R., Brown, J. C., Sanchez-David, R. Y., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00908-w · Cited by 731
Pietschmann, T., Kaul, A., Koutsoudakis, G., Shavinskaya, A., Kallis, S., Steinmann, E., Abid, K., Negro, F., Dreux, M., Cosset, F.-L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504877103 · Cited by 730
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697
Does the Agent of Scrapie Replicate without Nucleic Acid ?
ALPER, T., CRAMP, W. A., HAIG, D. A., & CLARKE, M. C. (1967) · Nature · doi:10.1038/214764a0 · Cited by 691
The effect of temperature on persistence of SARS-CoV-2 on common surfaces
Riddell, S., Goldie, S., Hill, A., Eagles, D., & Drew, T. W. (2020) · Virology Journal · doi:10.1186/s12985-020-01418-7 · Cited by 596
On the Calculation of TCID50 for Quantitation of Virus Infectivity
Lei, C., Yang, J., Hu, J., & Sun, X. (2021) · Virologica Sinica · doi:10.1007/s12250-020-00230-5 · Cited by 493
Thompson, W. R. (1947) · Bacteriological Reviews · doi:10.1128/br.11.2.115-145.1947 · Cited by 488
Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies
Wilhelm, A., Widera, M., Grikscheit, K., Toptan, T., Schenk, B., Pallas, C., Metzler, M., Kohmer, N., Hoehl, S., Helfritz, F. A., et al. (2021) · doi:10.1101/2021.12.07.21267432 · Cited by 440
Cliquet, F., Aubert, M., & Sagné, L. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00212-3 · Cited by 432
Virus isolation and quantitation
Hierholzer, J. C., & Killington, R. A. (1996) · Virology Methods Manual · doi:10.1016/b978-012465330-6/50003-8 · Cited by 425
The exceptionally small size of the scrapie agent
Alper, T., Haig, D. A., & Clarke, M. C. (1966) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(66)90478-5 · Cited by 414
Eggers, M., Koburger-Janssen, T., Eickmann, M., & Zorn, J. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0200-7 · Cited by 386
Garbutt, M., Liebscher, R., Wahl-Jensen, V., Jones, S., Möller, P., Wagner, R., Volchkov, V., Klenk, H.-D., Feldmann, H., & Ströher, U. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5458-5465.2004 · Cited by 381
Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions
Steinmann, E., Penin, F., Kallis, S., Patel, A. H., Bartenschlager, R., & Pietschmann, T. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030103 · Cited by 372
Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene
Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J., Richman, D. D., & Guatelli, J. C. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.2906-2914.1994 · Cited by 364
Merz, A., Long, G., Hiet, M.-S., Brügger, B., Chlanda, P., Andre, P., Wieland, F., Krijnse-Locker, J., & Bartenschlager, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.175018 · Cited by 356
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
Ratnesar-Shumate, S., Williams, G., Green, B., Krause, M., Holland, B., Wood, S., Bohannon, J., Boydston, J., Freeburger, D., Hooper, I., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa274 · Cited by 356
Isolation and Some Characteristics of an Agent Inducing Anemia in Chicks
Yuasa, N., Taniguchi, T., & Yoshida, I. (1979) · Avian Diseases · doi:10.2307/1589567 · Cited by 351
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
Huo, J., Zhao, Y., Ren, J., Zhou, D., Duyvesteyn, H. M. E., Ginn, H. M., Carrique, L., Malinauskas, T., Ruza, R. R., Shah, P. N. M., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.06.010 · Cited by 332
Horowitz, B., Wiebe, M. E., Lippin, A., & Stryker, M. H. (1985) · Transfusion · doi:10.1046/j.1537-2995.1985.25686071422.x · Cited by 324
Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces
Biryukov, J., Boydston, J. A., Dunning, R. A., Yeager, J. J., Wood, S., Reese, A. L., Ferris, A., Miller, D., Weaver, W., Zeitouni, N. E., et al. (2020) · mSphere · doi:10.1128/msphere.00441-20 · Cited by 318
Oberste, M. S., Maher, K., Schnurr, D., Flemister, M. R., Lovchik, J. C., Peters, H., Sessions, W., Kirk, C., Chatterjee, N., Fuller, S., et al. (2004) · Journal of General Virology · doi:10.1099/vir.0.79925-0 · Cited by 303
Keyaerts, E., Vijgen, L., Pannecouque, C., Van Damme, E., Peumans, W., Egberink, H., Balzarini, J., & Van Ranst, M. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.03.003 · Cited by 294
Efficacy of various disinfectants against SARS coronavirus
Rabenau, H. F., Kampf, G., Cinatl, J., & Doerr, H. W. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.12.023 · Cited by 271
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
Zhou, D., Duyvesteyn, H. M. E., Chen, C.-P., Huang, C.-G., Chen, T.-H., Shih, S.-R., Lin, Y.-C., Cheng, C.-Y., Cheng, S.-H., Huang, Y.-C., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0480-y · Cited by 274
Measles Viruses with Altered Envelope Protein Cytoplasmic Tails Gain Cell Fusion Competence
Cathomen, T., Naim, H. Y., & Cattaneo, R. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1224-1234.1998 · Cited by 272
Kaul, A., Stauffer, S., Berger, C., Pertel, T., Schmitt, J., Kallis, S., Zayas Lopez, M., Lohmann, V., Luban, J., & Bartenschlager, R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000546 · Cited by 267
In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae
Une, T., & Brubaker, R. R. (1984) · Infection and Immunity · doi:10.1128/iai.43.3.895-900.1984 · Cited by 263
Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated Sunlight
Schuit, M., Ratnesar-Shumate, S., Yolitz, J., Williams, G., Weaver, W., Green, B., Miller, D., Krause, M., Beck, K., Wood, S., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa334 · Cited by 263
Burns, C. C., Shaw, J., Campagnoli, R., Jorba, J., Vincent, A., Quay, J., & Kew, O. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3259-3272.2006 · Cited by 259
A new reporter cell line to monitor HIV infection and drug susceptibility in vitro
Gervaix, A., West, D., Leoni, L. M., Richman, D. D., Wong-Staal, F., & Corbeil, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4653 · Cited by 252
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8366-8377.2003 · Cited by 233
Eggers, M., Eickmann, M., & Zorn, J. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0091-9 · Cited by 229
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
Vanshylla, K., Di Cristanziano, V., Kleipass, F., Dewald, F., Schommers, P., Gieselmann, L., Gruell, H., Schlotz, M., Ercanoglu, M. S., Stumpf, R., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.04.015 · Cited by 153
Burns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02954-12 · Cited by 153
Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material
Lock, M., McGorray, S., Auricchio, A., Ayuso, E., Beecham, E. J., Blouin-Tavel, V., Bosch, F., Bose, M., Byrne, B. J., Caton, T., et al. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.223 · Cited by 131
Lee, G. I., Saravia, J., You, D., Shrestha, B., Jaligama, S., Hebert, V. Y., Dugas, T. R., & Cormier, S. A. (2014) · Particle and Fibre Toxicology · doi:10.1186/s12989-014-0057-1 · Cited by 119
Eagle, H., Fleischman, R., & Musselman, A. D. (1950) · Journal of Bacteriology · doi:10.1128/jb.59.5.625-643.1950 · Cited by 114
Bat genomes illuminate adaptations to viral tolerance and disease resistance
Morales, A. E., Dong, Y., Brown, T., Baid, K., Kontopoulos, D. G., Gonzalez, V., Huang, Z., Ahmed, A.-W., Bhuinya, A., Hilgers, L., et al. (2025) · Nature · doi:10.1038/s41586-024-08471-0 · Cited by 78
Shen, C. F., Guilbault, C., Li, X., Elahi, S. M., Ansorge, S., Kamen, A., & Gilbert, R. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.07.003 · Cited by 75
Manufacturing Clinical Grade Recombinant Adeno-Associated Virus Using Invertebrate Cell Lines
Kotin, R. M., & Snyder, R. O. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.042 · Cited by 59
Transmission and pathogenicity of encephalomyocarditis virus (EMCV) among rats
Spyrou, V., Maurice, H., CharalambosBillinis, Papanastassopoulou, M., Psalla, D., Nielen, M., Koenen, F., & Papadopoulos, O. (2004) · Veterinary Research · doi:10.1051/vetres:2003044 · Cited by 56
Sundh, H., Calabrese, S., Jutfelt, F., Niklasson, L., Olsen, R.-E., & Sundell, K. (2011) · Aquaculture · doi:10.1016/j.aquaculture.2011.08.011 · Cited by 55
Identification of a calicivirus isolate of unknown origin
Oehmig, A., Büttner, M., Weiland, F., Werz, W., Bergemann, K., & Pfaff, E. (2003) · Journal of General Virology · doi:10.1099/vir.0.19042-0 · Cited by 53
White, J. A., Blum, J. S., Hosken, N. A., Marshak, J. O., Duncan, L., Zhu, C., Norton, E. B., Clements, J. D., Koelle, D. M., Chen, D., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.32253 · Cited by 51
Siegers, J. Y., van de Bildt, M. W. G., Lin, Z., Leijten, L. M., Lavrijssen, R. A. M., Bestebroer, T., Spronken, M. I. J., De Zeeuw, C. I., Gao, Z., Schrauwen, E. J. A., et al. (2019) · Journal of Virology · doi:10.1128/jvi.02273-18 · Cited by 40
Cui, A., Yu, D., Zhu, Z., Meng, L., Li, H., Liu, J., Liu, G., Mao, N., & Xu, W. (2010) · Virology Journal · doi:10.1186/1743-422x-7-72 · Cited by 36
Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis
Viktorova, E. G., Khattar, S. K., Kouiavskaia, D., Laassri, M., Zagorodnyaya, T., Dragunsky, E., Samal, S., Chumakov, K., & Belov, G. A. (2018) · Journal of Virology · doi:10.1128/jvi.00976-18 · Cited by 29
D’Accolti, M., Soffritti, I., Bonfante, F., Ricciardi, W., Mazzacane, S., & Caselli, E. (2021) · Viruses · doi:10.3390/v13112227 · Cited by 29
Experimental evidence for temporal uncoupling of brain Aβ deposition and neurodegenerative sequelae
Rother, C., Uhlmann, R. E., Müller, S. A., Schelle, J., Skodras, A., Obermüller, U., Häsler, L. M., Lambert, M., Baumann, F., Xu, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34538-5 · Cited by 28
Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids
Rahmani, W., Chung, H., Sinha, S., Bui-Marinos, M. P., Arora, R., Jaffer, A., Corcoran, J. A., Biernaskie, J., & Chun, J. (2022) · iScience · doi:10.1016/j.isci.2022.103818 · Cited by 25
Molecular basis for shifted receptor recognition by an encephalitic arbovirus
Fan, X., Li, W., Oros, J., Plante, J. A., Mitchell, B. M., Plung, J. S., Basu, H., Nagappan-Chettiar, S., Boeckers, J. M., Tjang, L. V., et al. (2025) · Cell · doi:10.1016/j.cell.2025.03.029 · Cited by 17
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
Singanallur, N. B., van Vuren, P. J., McAuley, A. J., Bruce, M. P., Kuiper, M. J., Gwini, S. M., Riddell, S., Goldie, S., Drew, T. W., Blasdell, K. R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883612 · Cited by 15
(2022) · doi:10.3390/v14040800 · Cited by 9
Metadata
- Authors
- Kärber, G.
- Venue
- Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie
- Published
- 1931-07
- Volume
- 162
- Issue
- 4
- Pages
- 480-483
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W1989069389
- Cited by
- 3,104
- References
- 1
- FWCI
- 20.46
- Type
- journal article
- Language
- de
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.